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Cystic fibrosis (CF) is a debilitating human disease caused by mutations in the cystic fibrosis transmembrane conductance regulator
(CFTR) gene. The recently solved crystal structures of the murine CFTR nucleotide binding domain (NBD) provide insight into the
molecular basis of several CF-causing mutations. In addition, the NBD structures reveal several unexpected findings that may have
implications concerning CFTR function. In this mini-review, we discuss the key structural features of ATP Binding Cassette (ABC)
transporter NBDs, as well as highlight how structural information has aided our understanding of the ATP-regulated solute transport cycle.
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fibrosis transmembrane conductance regulator (CFTR), is
a member of the ABC transporter supergene family. ATP
Binding Cassette (ABC) transporters perform vital functions
such as nutrient uptake, toxin export and cell-to-cell com-
munication in eukaryotes, eubacteria and archeabacteria.
They are responsible for the ATP-dependent transport of
an incredibly diverse set of solutes across biological mem-
branes [1–3], including sugars, amino acids, anions, chro-
mophores, drugs, peptides, proteins and lipids. As such, it is
not surprising that they form one of the largest supergene
families in microbial systems nor that their dysfunction
underlies many debilitating human diseases, including CF.
The operon organization of microbial ABC transport
systems and the architecture of eukaryotic ABC transporters
suggest that the minimal functional unit of the transporters
consists of two nucleotide binding domains (NBDs) or
cassettes and two transmembrane domains (TMDs) [3].
An alignment of the NBDs from a number of prokaryotic
and eukaryotic ABC transporters is shown in Fig. 1. Each
NBD contains Walker A and B consensus sequences critical
for interactions with the nucleotide, and Signature, Q-loop1569-1993/$ - see front matter D 2004 European Cystic Fibrosis Society. Publish
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binding and hydrolysis in the NBDs to conformational
changes in the TMDs. This conserved structure suggests
that all ABC transporters share common aspects of their
mechanochemistry, regardless of whether the solute in
question is a protein, a lipid, a sugar or an anion. At present,
our understanding of the detailed mechanism by which the
chemical energy, released by ATP binding and hydrolysis, is
conformationally coupled through the NBDs to the TMDs
to permit solute movement remains incomplete.
Like other ABC transporters, CFTR is composed of two
NBDs and two TMDs which form a conduit which mediates
conduction of the chloride (Cl) ion across the membrane.
In addition, CFTR contains a regulatory domain (R) whose
phosphorylation by protein kinase A (PKA) is required for
activation of CFTR Cl channel activity. In contrast to the
ABC pumps, interaction of ATP with the CFTR-NBDs is
required for gating the activated channel rather than actively
transporting solute. CF-causing mutations in CFTR can
disrupt this function either indirectly by interfering with
the formation of the native three-dimensional structure of
the channel (i.e., folding) or more directly by interfering
with the mechanochemistry of the activation, gating and
conduction processes. Detailed knowledge of the structure
of CFTR is key to understanding the molecular pathology of
both types of disease-associated mutations.
Recently published biochemical and structural analyses
of soluble, isolated ABC transporter NBDs [4–7] haveed by Elsevier B.V. All rights reserved.
Fig. 1. Alignment of ABC transporter nucleotide binding domains. The human and mouse CFTR N- and C-terminal NBDs are aligned with other cassette
sequences for which structures are available. The position of F508 is indicated by D; the canonical NBD sequences and the NBD1 specific insertion sequence
are also labeled. Note that the generally conserved catalytic glutamate at the C-terminus of the Walker B sequence and the otherwise conserved histidine in the
H-loop are both serine residues in the human and murine CFTR-NBD1.
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They indicate that nucleotide-dependent association–disso-
ciation of the two cassettes plays a central role in harvesting
the energy of ATP binding and hydrolysis [6,7]. These
studies show that mutant NBDs can form stable symmetrical
dimers in the presence of ATP. This dimer places two ATPs
at the dimer interface, between the Walker A and B
consensus sequences of one domain and the Signature
sequence of the opposing domain with the two ATPs
forming the bulk of the interface. The measured Hill
coefficient of 1.7 for the activity of the homodimeric ABC
transporters is consistent with a cooperative two-site mech-
anism. Upon hydrolysis, electrostatic mismatch at the active
site [6] and subdomain rotation within the NBD [4,5] lead to
a rapid dissociation event. This arrangement neatly solves
the problem of the observed positive cooperativity of
ATPase activity catalyzed by the isolated NBDs [6,8,9]
and the open active site and structurally remote transporter
Signature sequence in the monomeric NBD structures
previously determined by us and others [4,5,10]. Recent
structures of intact ABC transporters MsbA and BtuCD
reveal that the TMDs interact with one surface of this dimer
[11,12], and thus suggest that NBD interactions can be
efficiently coupled to a scissoring motion of the integral
membrane solute pathway of the transporters [13].In contrast to the homodimeric NBDs, the two NBDs of
CFTR are distinct from each other in important ways.
Hydrolytically active NBDs have a catalytic glutamate
residue at the end of the Walker B consensus (Fig. 1).
While NBD2 (the C-terminal NBD of CFTR) has a
glutamate, NBD1 (the N-terminal NBD) has a serine at
this position. In addition, NBD1 also lacks a critical
histidine residue in the H-loop. Recent studies with the
murine CFTR-NBD1 indicate that it does not catalyze
significant hydrolysis of ATP [14]. NBD1 does contain
the canonical LSGGQ in the highly conserved Signature
sequence while NBD2 has a more unusual LSHGH se-
quence. Thus, if CFTR-NBD1 and -NBD2 dimerize to
form an ATP sandwich dimer like the homodimeric NBDs,
one of the two nucleotide sites (Walker A and B from
NBD1 and the signature from NBD2) is very unusual,
perhaps consistent with CFTR’s identity as a channel in a
family of transporters.
Recently, six structures of murine CFTR-NBD1, which is
78% identical to the human CFTR-NBD1, have been solved
at high resolution [14]. The structure of NBD1 with AMP-
PNP bound (Fig. 2) highlights both the similarities and
differences between CFTR-NBD1 and the other ABC trans-
porter NBDs solved to date and discussed above. No
significant conformational changes between the six murine
Fig. 2. Structure of murine CFTR-NBD1. A stereo ribbon image of mouse CFTR-NBD1 bound with AMP-PNP and Mg2 + (pdb: 1Q3H) is shown with the
putative dimer interface facing out of the page. Note that the C-terminal helix partially occludes the dimer interface, requiring either significant structural
rearrangements in NBD1 or modification of the canonical NBD structure to allow formation of the previously described nucleotide-sandwich dimer. The large
insertion between the first two strands (not visualized in this structure, see Fig. 1) becomes partially ordered upon phosphorylation and also lies across the
putative dimer interface. The potential NBD–TMD interface is at the bottom of the view. In this orientation, the TM helices would reside in the plane of the
page, and the intracellular loops between the spans would interact with the F508 face of the cassette.
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tide bound. The fold of the new CFTR-NBD1 structures is
very similar to that of the other ATP binding cassettes with a
beta-sheet sub-domain, an alpha–beta core containing the
Walker A and B sequences (similar to the RecA/F1 fold)
and an alpha helical sub-domain that contains the Signature
sequence and is the site of the most common CF-causing
mutation, deletion of phenylalanine 508 (F508del). This
residue is located on the surface of NBD1 at a position
remote from the NBD dimer interface, but presumed to be at
or near the interface for interaction with the TMDs. The
location of F508 at the putative NBD–TMD interface is
consistent with previous studies where the deletion of F508
did not significantly impact the stability of the isolated
domain but destabilized the intact CFTR structure [15–17].
CFTR-NBD1 contains an insertion between the first and
second beta strands (residues 406–434) which is largely
disordered in the crystals. However, when NBD1 is phos-
phorylated, a partial ordering of this insertion is observed
which may partially occlude the nucleotide [14] and perhaps
accounts for the very unusual nucleotide binding kinetics
observed [18]. Thus, in contrast to earlier predictions of the
boundaries of NBD1, the first strand is composed of
residues 393–400, and the tryptophan at position 407 is
in position to potentially interact with the nucleotide base.
However, in all of the CFTR-NBD1 structures, the nucleo-
tide is bound in a quite unusual conformation including an
‘anti’ m base torsional angle. NBD1 also has additional
secondary structural elements that serve to further alter the
putative dimer interface, including a helix at the extreme C-
terminus that has previously been assigned to the R domain.
Thus, formation of a canonical ATP sandwich dimer will
either require reorientation of these elements or compensa-
tory changes at the NBD2 interface to accommodate them.
These initial structural characterizations of CFTR and its
homologues provide new insight about the function anddysfunction of this important protein. Structures of intact
CFTR, various functional states and mutant variants are
necessary for elucidating a complete mechanistic under-
standing of CFTR function and the molecular pathology
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